LPL Financial LLC lifted its stake in Haleon plc (NYSE:HLN - Free Report) by 21.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,160,459 shares of the company's stock after buying an additional 205,505 shares during the quarter. LPL Financial LLC's holdings in Haleon were worth $11,071,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Thrivent Financial for Lutherans boosted its position in Haleon by 69.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 55,593 shares of the company's stock worth $588,000 after purchasing an additional 22,701 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Haleon by 41.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 203,583 shares of the company's stock worth $2,154,000 after buying an additional 59,719 shares in the last quarter. Benjamin Edwards Inc. acquired a new stake in Haleon during the third quarter valued at $805,000. Hilltop Holdings Inc. purchased a new position in Haleon in the third quarter valued at $133,000. Finally, HighTower Advisors LLC raised its position in shares of Haleon by 27.2% in the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company's stock worth $3,701,000 after acquiring an additional 74,970 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
HLN has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Hsbc Global Res lowered shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Sanford C. Bernstein cut shares of Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Six investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $10.95.
View Our Latest Analysis on HLN
Haleon Price Performance
Shares of Haleon stock traded up $0.08 during trading hours on Tuesday, reaching $9.35. 20,279,401 shares of the company's stock were exchanged, compared to its average volume of 6,787,212. The business has a fifty day moving average of $10.02 and a two-hundred day moving average of $9.84. The company has a market capitalization of $42.22 billion, a P/E ratio of 27.49, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a 1 year low of $7.99 and a 1 year high of $10.80.
Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. As a group, research analysts predict that Haleon plc will post 0.43 earnings per share for the current fiscal year.
Haleon Increases Dividend
The business also recently declared a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a $0.1166 dividend. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a boost from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio (DPR) is currently 58.97%.
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
